Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Synctial Virus”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Not applicableLooking for participantsNCT06784739
What this trial is testing

COMMUNITY - the COVID-19 Immunity Study

Who this might be right for
COVID 19Respiratory Synctial VirusInfluenza Virus+1 more
Danderyd Hospital 5,500
Not applicableEnded earlyNCT06735612
What this trial is testing

Respiratory Syncytial Virus Infection In Exacerbations of Chronic Obstructive Pulmonary Diasease: The RECODE Study

Who this might be right for
Respiratory Synctial VirusCOPDChronic Obstructive Pulmonary Disease (COPD)+1 more
Fundacio Privada Mon Clinic Barcelona 716
Early research (Phase 1)Study completedNCT02491463
What this trial is testing

Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults

Who this might be right for
Respiratory Synctial Virus Infections
GlaxoSmithKline 73
Not applicableLooking for participantsNCT07653347
What this trial is testing

Infant RSV Immunity Study

Who this might be right for
Respiratory Synctial VirusAsthma Childhood
University of British Columbia 300
Not applicableNot Yet RecruitingNCT07217639
What this trial is testing

Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings

Who this might be right for
COVID -19Influenza AInfluenza B+3 more
Aptitude Medical Systems 2,000
Early research (Phase 1)Study completedNCT02296463
What this trial is testing

A Phase I Randomized, Observer-Blinded, Dose-Ranging Study in Healthy Subjects 24 to <72 Months of Age

Who this might be right for
Respiratory Synctial Virus
Novavax 32
Large-scale testing (Phase 3)Looking for participantsNCT06775405
What this trial is testing

Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants

Who this might be right for
Respiratory Synctial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 180
Not applicableLooking for participantsNCT06856967
What this trial is testing

Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age.

Who this might be right for
Respiratory Synctial Virus Infections
Meyer Children's Hospital IRCCS 138
Testing effectiveness (Phase 2)Study completedNCT06890429
What this trial is testing

Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults

Who this might be right for
Respiratory Synctial Virus Infections
Research Institute of Influenza, Russia 120